Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis

Smith, Sarah E.; Kurbatova, Ekaterina V.; Cavanaugh, Joseph S.; Cegielski, J. Peter

doi:10.5588/ijtld.11.0445

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis

Published Date:

Feb 2012

Publisher's site:

http://dx.doi.org/10.5588/ijtld.11.0445 New Site Icon

Source:

Int J Tuberc Lung Dis. 16(2):203-205.

Language:

English

[PDF-96.51 KB]

Details:

Alternative Title:

Int J Tuberc Lung Dis

Personal Author:

Smith, Sarah E. ; Kurbatova, Ekaterina V. ; Cavanaugh, Joseph S. ; Cegielski, J. Peter ;

Description:

Following the World Health Organization's endorsement of the Xpert® MTB/RIF assay, which rapidly and simultaneously diagnoses tuberculosis (TB) and detects resistance to rifampin (RMP), the question arises to what extent RMP resistance is an adequate marker for multidrug-resistant TB (MDR-TB). A retrospective analysis of data from >81 countries and subnational settings demonstrated that >40% of RMP-resistant isolates from new TB cases did not display resistance to isoniazid (INH) in settings with relatively low MDR-TB prevalence (one third of all countries and subnational settings). Results indicated the need for INH susceptibility testing in addition to RMP susceptibility testing.

Pubmed ID:

22136739

Pubmed Central ID:

PMC4593497

Document Type:

Journal Article

Funding:

1000553038/Intramural CDC HHS/United States ; IES3/Intramural CDC HHS/United States ;

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

nihms725526.nxml

text/plain

No Related Documents.

You May Also Like:

rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism.

Personal Author:

Bobadilla-del-Valle, M.; Ponce-de-Leon, A.; Arenas-Huertero, C.; Vargas-Alarcon, G.; Kato-Maeda, M.; Small, P. M.; Couary, P.; Ruiz-Palacios, G. M.; Sifuentes-Osornio, J.;

Published Date:

2001 Nov-Dec

Source:

Emerg Infect Dis. 7(6):1010-1013.

Description:

The use of polymerase chain reaction-single-stranded conformational polymorphism (PCR-SSCP) to study rpoB gene mutations in rifampin-resistant (RIFr) Mycobacterium tuberculosis has yielded contradictory results. To determine the sensitivity of this m...

File Type:

[PDF - 42.49 KB]
Drug-Resistant Tuberculosis among Children, China, 2006–2015

Personal Author:

Tao, Ning-ning; He, Xiao-chun; Zhang, Xian-xin; Liu, Yao; Yu, Chun-bao; Li, Huai-chen;

Published Date:

Nov 2017

Source:

Emerg Infect Dis. 23(11):1800-1805.

Description:

Microbial drug resistance has become a major public health concern worldwide. To acquire epidemiologic data on drug-resistant tuberculosis (DR TB) among children, a major cause of illness and death for this population, we conducted a retrospective st...

File Type:

[PDF - 780.00 KB]
Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs

Personal Author:

Kurbatova, Ekaterina V.; Cavanaugh, J. Sean; Shah, N. Sarita; Wright, Abigail; Kim, HeeJin; Metchock, Beverly; Van Deun, Armand; Barrera, Lucia; Boulahbal, Fadila; Richter, Elvira; Martín-Casabona, Nuria; Arias, Fabiola; Zemanova, Ilona; Drobniewski, Francis; Silva, Anabela Santos; Coulter, Christopher; Lumb, Richard; Cegielski, J. Peter;

Published Date:

2012

Source:

Int J Tuberc Lung Dis. 16(3):355-357.

Description:

Based on data from 14 Supranational Tuberculosis (TB) Reference Laboratories worldwide, the proportion of rifampicin (RMP) resistant isolates that were isoniazid (INH) susceptible by phenotypic drug susceptibility testing varied widely (0.5-11.6%). R...

File Type:

[PDF - 120.90 KB]
RIFAMPIN-RESISTANT TUBERCULOSIS IN THE UNITED STATES, 1998–2014

Personal Author:

Sharling, Lisa; Marks, Suzanne M.; Goodman, Michael; Chorba, Terence; Mase, Sundari;

Published Date:

June 22 2019

Source:

Clin Infect Dis.

Description:

BackgroundMonoresistance to rifamycins necessitates longer and more toxic regimens for tuberculosis (TB). We examined characteristics and mortality associated with rifampin-monoresistant (RMR) TB in the United States.MethodsWe analyzed Mycobacterium ...

Public Access
Available on:

December 22, 2020
Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola

Personal Author:

Rando-Segura, Ariadna; Aznar, María Luisa; Moreno, María Milagros; Espasa, Mateu; Sulleiro, Elena; Bocanegra, Cristina; Gil, Eva; Eugénio, Arlete N.E.; Escartin, Carlos; Zacarias, Adriano; Vegue, Josep; Katimba, Domingos; Vivas, María Carmen; Gabriel, Estevao; Marina, María Concepción; Mendioroz, Jacobo; López, María Teresa; Pumarola, Tomas; Molina, Israel; Tórtola, María Teresa;

Published Date:

Mar 2018

Source:

Emerg Infect Dis. 24(3):569-572.

Description:

We found high prevalence rates of multidrug-resistant tuberculosis among retreatment patients (71.1%) and persons with new cases (8.0%) in Angola. These findings are of concern but should be interpreted with caution. A national drug-resistance survey...

File Type:

[PDF - 1.57 MB]